Close

Form 4 Silk Road Medical Inc For: May 20 Filed by: Buchanan Lucas W.

August 12, 2022 8:46 PM EDT
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person *
Buchanan Lucas W.

(Last) (First) (Middle)
C/O SILK ROAD MEDICAL, INC.
1213 INNSBRUCK DRIVE

(Street)
SUNNYVALE CA 94089

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Silk Road Medical Inc [ SILK ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
COO/CFO
3. Date of Earliest Transaction (Month/Day/Year)
05/20/2022
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/10/2022   M (1)   7,180 A $ 4.73 255,930 D  
Common Stock 08/10/2022   S (1)   7,180 D $ 47.0262 (2) 248,750 D  
Common Stock 08/10/2022   M (1)   2,807 A $ 12.15 251,557 D  
Common Stock 08/10/2022   S (1)   2,807 D $ 47.0262 (2) 248,750 D  
Common Stock 08/10/2022   M (1)   2,564 A $ 4.73 251,314 D  
Common Stock 08/10/2022   S (1)   2,564 D $ 47.0262 (2) 248,750 D  
Common Stock 08/10/2022   M (1)   4,913 A $ 12.15 253,663 D  
Common Stock 08/10/2022   S (1)   4,913 D $ 47.0262 (2) 248,750 D  
Common Stock 05/20/2022   A (3) V 550 A $ 24.51 249,300 D  
Common Stock 08/10/2022   S (4)   7,536 D $ 47.0262 (2) 241,764 D  
Common Stock 08/11/2022   S (4)   25,000 D $ 48.6042 (5) 216,764 D  
Common Stock 08/12/2022   S (4)   25,000 D $ 47.7889 (6) 191,764 D  
Common Stock               13,518 I Buchanan Grandchildren's Irrevocable Trust (7)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Option (right to buy) $ 4.73 08/10/2022   M (1)     7,180 09/01/2017 (8) 11/30/2027 Common Stock 7,180 $ 0 0 D  
Option (right to buy) $ 12.15 08/10/2022   M (1)     2,807 09/01/2017 (8) 11/30/2027 Common Stock 2,807 $ 0 0 D  
Option (right to buy) $ 4.73 08/10/2022   M (1)     2,564 09/01/2017 (8) 11/30/2027 Common Stock 2,564 $ 0 0 D  
Option (right to buy) $ 12.15 08/10/2022   M (1)     4,913 09/01/2017 (8) 11/30/2027 Common Stock 4,913 $ 0 0 D  
Explanation of Responses:
1. The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on June 13, 2022.
2. This transaction was executed in multiple trades at price ranging from $46.15 to $48.22. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
3. These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c).
4. The sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on June 13, 2022.
5. This transaction was executed in multiple trades at price ranging from $47.38 to $49.51. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
6. This transaction was executed in multiple trades at price ranging from $47.29 to $48.56. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
7. These shares are held directly by the Buchanan Grandchildren's Irrevocable Trust, for which the Reporting Person serves as a co-trustee.
8. All of the shares subject to this option are fully vested and exercisable as of the date hereof.
/s/Mhairi Jones, by power of attorney 08/12/2022
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings